| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3687916
Max Phase: Preclinical
Molecular Formula: C21H15Cl2FN2O3
Molecular Weight: 433.27
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(O)C[C@H](NC(=O)c1cccc(-c2ccccc2F)n1)c1cccc(Cl)c1Cl
Standard InChI: InChI=1S/C21H15Cl2FN2O3/c22-14-7-3-6-13(20(14)23)18(11-19(27)28)26-21(29)17-10-4-9-16(25-17)12-5-1-2-8-15(12)24/h1-10,18H,11H2,(H,26,29)(H,27,28)/t18-/m0/s1
Standard InChI Key: DMWVLDHXPWRALB-SFHVURJKSA-N
Associated Targets(Human)
Lysosomal protective protein 919 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 433.27 | Molecular Weight (Monoisotopic): 432.0444 | AlogP: 5.14 | #Rotatable Bonds: 6 |
| Polar Surface Area: 79.29 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 3.80 | CX Basic pKa: 0.51 | CX LogP: 5.10 | CX LogD: 1.84 |
| Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.56 | Np Likeness Score: -1.26 |
References
| 1. (2015) Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals, |
Source
Source(1):